Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amar Gajjar

Showing results (1-10 of 383) with videos related to

Pageof 39
Sort By:
Cancer|February 29, 2008
High-dose chemotherapy for recurrent medulloblastoma: time for a reappraisalAmar Gajjar
Pediatric Blood & Cancer|August 10, 2020
Medulloblastoma: Improving cure rates in tandem with reduction in short-term toxicities and long-term treatment-related morbiditiesAmar Gajjar
Pediatric Blood & Cancer|February 11, 2010
Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumorsAmar Gajjar, Barry Pizer
The Oncologist|March 30, 2004
Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologistAlberto Broniscer, Amar Gajjar
CNS Oncology|December 3, 2014
Molecular characteristics of pediatric high-grade gliomasOmar Chamdine, Amar Gajjar
Pediatric Clinics of North America|December 2, 2014
Brain tumorsMurali Chintagumpala, Amar Gajjar
Journal of Neuro-Oncology|October 1, 2005
Molecular biology of medulloblastoma: will it ever make a difference to clinical management?Richard J Gilbertson, Amar Gajjar
Frontiers in Oncology|September 19, 2012
Atypical teratoid rhabdoid tumor: current therapy and future directionsKevin F Ginn, Amar Gajjar
Neuro-Oncology|October 25, 2024
Determining risk features for medulloblastoma in the molecular eraNicholas G Gottardo, Amar Gajjar
Pediatric Blood & Cancer|December 30, 2014
The management of children and adolescents with medulloblastoma in low and middle income countriesAmar Gajjar, Jonathan L Finlay
Pageof 39

Showing results (1-10 of 383) with videos related to

Sort By:
Pageof 39
Cancer|February 29, 2008
High-dose chemotherapy for recurrent medulloblastoma: time for a reappraisalAmar Gajjar
Pediatric Blood & Cancer|August 10, 2020
Medulloblastoma: Improving cure rates in tandem with reduction in short-term toxicities and long-term treatment-related morbiditiesAmar Gajjar
Pediatric Blood & Cancer|February 11, 2010
Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumorsAmar Gajjar, Barry Pizer
The Oncologist|March 30, 2004
Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologistAlberto Broniscer, Amar Gajjar
CNS Oncology|December 3, 2014
Molecular characteristics of pediatric high-grade gliomasOmar Chamdine, Amar Gajjar
Pediatric Clinics of North America|December 2, 2014
Brain tumorsMurali Chintagumpala, Amar Gajjar
Journal of Neuro-Oncology|October 1, 2005
Molecular biology of medulloblastoma: will it ever make a difference to clinical management?Richard J Gilbertson, Amar Gajjar
Frontiers in Oncology|September 19, 2012
Atypical teratoid rhabdoid tumor: current therapy and future directionsKevin F Ginn, Amar Gajjar
Neuro-Oncology|October 25, 2024
Determining risk features for medulloblastoma in the molecular eraNicholas G Gottardo, Amar Gajjar
Pediatric Blood & Cancer|December 30, 2014
The management of children and adolescents with medulloblastoma in low and middle income countriesAmar Gajjar, Jonathan L Finlay
Pageof 39